Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy protection promises.
In its announcement of the acquisition, Rege… [1581 chars]
Biotech company Regeneron to buy bankrupt 23andMe for $256M
